Rheumatoid arthritis doesn’t have a single root cause. It develops when a genetically susceptible immune system encounters the right combination of environmental triggers, causing it to attack the body’s own joint tissue. The process begins years before any joint pain appears, with detectable autoantibodies circulating in the blood an average of 3 to 18 years before diagnosis. Understanding the interplay of genetics, environment, hormones, and the microbiome explains why some people develop the disease and others don’t.
The Genetic Foundation
About 60% of rheumatoid arthritis risk is heritable, and the strongest genetic link involves a specific region of the immune system’s blueprint. A set of gene variants called HLA-DRB1 “shared epitope” alleles code for immune proteins that sit on the surface of cells and present fragments of foreign invaders to the rest of the immune system. In people who carry these variants, the presentation process goes wrong: the immune system gets trained to recognize the body’s own modified proteins as threats.
The shared epitope explains about 18% of the total genetic risk for antibody-positive rheumatoid arthritis, the most common and typically more aggressive form. But genetics alone isn’t destiny. Most people who carry these gene variants never develop the disease. Something in the environment has to pull the trigger.
How Smoking Starts the Process in the Lungs
Cigarette smoke is the single strongest environmental risk factor. It doesn’t just increase inflammation generally. It drives a specific chemical change in lung tissue called citrullination, where the amino acid arginine in proteins gets converted into citrulline. This small molecular tweak makes those proteins look foreign to the immune system, especially in people carrying the shared epitope genes.
The immune system then produces anti-citrullinated protein antibodies (ACPA), which are the hallmark autoantibodies of rheumatoid arthritis. The combination of carrying the shared epitope genes and smoking creates a risk that’s far greater than either factor alone. This gene-environment interaction is one of the best-documented examples in all of autoimmune disease. Smoking also shifts the balance of immune signaling molecules toward a more inflammatory profile and increases susceptibility to infections that can further prime the immune system.
The Gut and Oral Microbiome
The bacteria living in your gut and mouth play a surprisingly central role. In people with new-onset, untreated rheumatoid arthritis, researchers have found a striking expansion of a gut bacterium called Prevotella copri. This overgrowth comes at the expense of bacterial groups associated with anti-inflammatory activity and the production of regulatory immune cells. In mouse studies, colonization with P. copri enhanced susceptibility to inflammatory disease, consistent with a pro-inflammatory role. The picture that emerges is one where a Prevotella-dominated gut microbiome supports and perpetuates inflammation in a genetically susceptible host.
The mouth tells a parallel story. A gum disease bacterium called Porphyromonas gingivalis is the only known bacterium that produces its own version of the enzyme responsible for citrullination. It breaks down human proteins at specific sites and then citrullinates them, creating the same modified proteins that trigger ACPA production. This makes periodontal disease a plausible early link in the chain leading to rheumatoid arthritis, and epidemiological studies consistently show higher rates of gum disease in people with RA.
Hormones and the Female Risk
Women develop rheumatoid arthritis two to three times more often than men, and the timing of onset offers a strong clue about why. Post-menopausal women have a 35% higher risk of developing RA compared to pre-menopausal women. The risk is even more dramatic for women who experience early menopause (before age 45), who face nearly three times the odds of developing the disease.
The decline in estrogen that accompanies menopause shifts the immune system toward a more aggressive, inflammation-promoting state. Estrogen normally helps maintain a balance between different types of immune responses. When levels drop, the immune system tilts toward the type of response that drives joint inflammation. This hormonal shift helps explain why RA onset peaks in women during their late 40s to 60s, coinciding with the menopausal transition.
Occupational and Dietary Triggers
Inhaling irritants at work can mirror the lung effects of smoking. Men exposed to silica dust, common in mining, stone cutting, and construction, have roughly double the risk of developing rheumatoid arthritis compared to unexposed men. Those in the most heavily exposed jobs, like rock drilling or stone crushing, face a threefold increase. The risk is strongest in men over 50, suggesting that cumulative exposure matters. Like cigarette smoke, silica particles likely trigger inflammation and protein modification in lung tissue.
Diet also plays a measurable role. A large study tracking over 207,000 people in the UK found that those with the highest consumption of ultra-processed foods had a 17% greater risk of developing RA compared to those who ate the least. The connection appears to work partly through increased systemic inflammation and changes in blood lipids and liver enzymes. While the effect size is modest compared to smoking or genetics, it represents a modifiable risk factor within anyone’s control.
The Long Buildup Before Symptoms
One of the most striking features of rheumatoid arthritis is how long the immune process simmers before joints start hurting. The autoantibodies that define the disease are detectable in the blood years, sometimes decades, before the first swollen knuckle. In one study tracking blood samples collected before diagnosis, IgG ACPA (the primary antibody subtype) was elevated an average of 17.9 years before RA was formally diagnosed. Other antibody types appeared closer to diagnosis, with the full panel typically positive within two years of symptom onset.
This prolonged “pre-clinical” phase means the immune system is slowly losing tolerance to the body’s own proteins over many years. The process likely starts at mucosal surfaces like the lungs, gums, or gut lining, where environmental triggers modify proteins and the immune system begins producing autoantibodies. Only later does the inflammation localize to the joints, possibly when circulating antibodies form immune complexes with citrullinated proteins in the joint lining and activate a cascade of inflammation.
Epigenetics: Where Environment Meets DNA
Your genes don’t change over your lifetime, but which genes are active or silent does. Environmental exposures like smoking leave chemical marks on DNA that alter how cells behave without changing the underlying genetic code. In rheumatoid arthritis, the cells lining the joints (called fibroblast-like synoviocytes) carry distinct patterns of these epigenetic marks. Once imprinted, these cells take on an aggressive, invasive character, actively contributing to joint destruction even in the absence of ongoing immune stimulation.
This helps explain why rheumatoid arthritis can be so persistent. The joint lining cells themselves become reprogrammed by the disease process, behaving almost like tumor cells in their tendency to proliferate and invade cartilage and bone. Smoking has been shown to alter these epigenetic patterns in airway tissue and circulating blood cells, providing a concrete mechanism linking environmental exposure to lasting changes in immune cell behavior.
Putting the Pieces Together
Rheumatoid arthritis develops through a sequence, not a single event. A person inherits immune system genes that make them susceptible. Over years, environmental exposures like smoking, silica dust, gum disease, or shifts in gut bacteria modify proteins in ways that confuse the immune system. Hormonal changes can accelerate the process by tilting immune balance toward inflammation. Epigenetic changes lock in aggressive cell behavior. Autoantibodies quietly accumulate, and eventually the immune attack concentrates in the joints, producing the pain, swelling, and stiffness that lead to a diagnosis.
No single factor is “the” root cause. But citrullination, the chemical modification of proteins that makes them look foreign to the immune system, sits at the center of the most common form of the disease. Every major risk factor, from the shared epitope genes to smoking to P. gingivalis in the gums, converges on this process. The immune system’s inability to tolerate citrullinated proteins is, as close as current science can identify, the core malfunction driving the disease.